The Leukemia & Lymphoma Society's (LLS's) academic grants support and encourage basic and translational leukemia, lymphoma and myeloma research.
LLS investigators are outstanding scientists at the forefront of leukemia, lymphoma and myeloma research at centers throughout the world. We award academic grants for studies that range from basic blood cancer research to research that uses the latest tools of genomics.
And we don't stop there. We're also dedicated to funding blood cancer research to help improve the quality of life for patients and their families with our projects studying long-term and late effects.
The New Idea Award is closed. Policies and Procedures Application Guidelines and Instructions Grant Terms - New Idea Award Introduction The Leukemia & Lymphoma Society is proud to announce the fourth year of The New Idea Award, a grant program designed to identify novel research strategies with a potential for high impact on blood cancer. Specifically, this program supports the init...
The CDP application process is NOW OPEN.
The Leukemia & Lymphoma Society's (LLS) Career Development Program (CDP) provides stipends so that you can devote yourself to researching questions of direct relevance to hematological malignancies and/or relevant pre-malignant conditions.
LLS offers career development awards to postdoctoral fe...
The TRP application process is NOW OPEN. The Translational Research Program puts you on the bench-to-bedside fast track when it comes to finding better treatment and cures for leukemia, lymphoma and myeloma. The Leukemia & Lymphoma Society funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application. APPLY NOW! Tran...
The SCOR application process is NOW OPEN. LLS’s Specialized Center of Research (SCOR) grant program is intended to bring together established investigators from one or several institutions to develop a focused research program, foster new interactions and cooperation, and enhance interdisciplinary research among the participants. The overall goal of this mechanism is to enhance the development of innovativ...
The MCL-RI application process is CLOSED. The Leukemia & Lymphoma Society (LLS) announces a competitive grant program to benefit mantle cell lymphoma (MCL) patients. This is a milestone-driven research program with an overarching goal to move discoveries quickly from the bench to the clinic. The program is intended to bring together at least 3 independent research projects that are integrated and support...
RTFCCR/LLS PATIENT-FOCUSED PREVENTION application process is OPEN. The Rising Tide Foundation for Clinical Cancer Research and the Leukemia & Lymphoma Society are partnering once again to launch an international competitive grant to advance breakthroughs in prevention for blood cancers. The grant is focused on addressing four critical topics and is endowed with a total of USD $3 million; 3-5 grants will be awa...
The SLP application process is CLOSED. Grant Terms - Screen to Lead Policies and Procedures Request for Proposals (Click here) The Leukemia & Lymphoma Society (LLS) is planning on re-initiating our special grant program, Screen to Lead Program (SLP) for FY17. A call for applications will be announced in July 2016 for a planned program launch in July 2017. SLP was previously run for two years...
The RTFCCR/LLS Patient-Focused Immunotherapy Research Grant for Blood Cancer application process is NOW CLOSED. Applications are currently under review. Application Guidelines & Instructions LLS Grant Terms The Rising Tide Foundation for Clinical Cancer Research (RTFCCR), a private foundation in Switzerland, is focused on funding promising, innovative translational studi...
The TCI application process is NOW CLOSED. The Leukemia & Lymphoma Society (LLS) is proud to announce the "Transforming CURES Initiative (TCI) - Intercepting Progression to Advanced Myeloid Blood Cancers," a new Request for Proposals (RFP) to identify and develop novel, safe and effective treatment paradigms for patients with hematological malignancies. LLS is very pleased that Janssen Pharmace...
The IWMF-LLS Strategic Research Roadmap Initiative application process is NOW CLOSED. Request for Proposals The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) and the Leukemia & Lymphoma Society (LLS) are proud to announce the IWMF-LLS STRATEGIC RESEARCH ROADMAP INITIATIVE - a Request for Proposals (RFP) to help further knowledge in four key domains of Walden...
The MPN Challenge grant application process is NOW CLOSED. The Leukemia & Lymphoma Society (LLS) is partnered with the MPN Research Foundation (MPNRF) to support a grant program whose objective is to change the trajectory and ultimate prognosis for patients with myeloproliferative neoplasms, particularly myelofibrosis, polycythemia vera and essential thrombocythemia. The MPN Challenge program represents ...
The Quest for CURES application process is NOW CLOSED. LLS has formed a partnership with Celgene to create the first of such RFPs that will build the foundation of this new LLS initiative. This initiative will identify and fund priority research areas, with support from biotech and pharmaceutical partners in order to address significant unmet medical needs. The near-term goal of this program is to advance the...
